[Treatment of chronic obstructive bronchopneumopathies].
Guidelines and statements from ERS, ATS, BTS and SPLF are now available for adequate treatment of COPD. The recommendations are summarised but the author emphasizes what has changed, what remains unchanged or was adapted and what is new and promising. The therapeutic approach tends also to improve symptoms, especially dyspnea, and quality of life. This is mainly obtained with a multidisciplinary team offering the patient a program of rehabilitation.
Sergysels
R
R
Clinique de Pneumologie, C.H.U. Saint-Pierre, U.L.B.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004417:Dyspnea / Q000517:prevention & control; D005060:Europe; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000534:rehabilitation / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011788:Quality of Life; D012138:Respiratory Therapy; D016540:Smoking Cessation; D014481:United States
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents